ইউরোপীয় ইউনিয়ন - স্লোভাক - EMA (European Medicines Agency)

virbac s.a. - rekombinantný omega interferón mačacieho pôvodu - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. v mačky nakazený fiv, úmrtnosť bola nízka (5%) a nebola ovplyvnená liečba.

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

recordati industria chimica e farmaceutica s.p.a., taliansko - fentikonazol - 54 - gynaecologica

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

recordati industria chimica e farmaceutica s.p.a., taliansko - fentikonazol - 54 - gynaecologica

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

omega medical imaging, llc 3400 st. johns parkway, suite 1020 fl 32771 sanford spojené štáty americké -

শ্লোভাকিয়া - স্লোভাক - ŠÚKL (Štátny ústav pre kontrolu liečiv)

dr. theiss naturwaren gmbh, nemecko - expektoranciá s výnimkou kombinácií s antitusikami - 94 - fytopharmaca